Amundi’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-784
Closed -$252K 2131
2026
Q1
$252K Buy
+784
New +$234K ﹤0.01% 1808
2025
Q4
Sell
-5,281
Closed -$1.22M 1877
2025
Q3
$1.22M Sell
5,281
-5,451
-51% -$1.12M ﹤0.01% 1124
2025
Q2
$2.23M Buy
10,732
+5,089
+90% +$980K ﹤0.01% 1061
2025
Q1
$1.09M Buy
5,643
+252
+5% +$52.1K ﹤0.01% 1307
2024
Q4
$1.16M Hold
5,391
﹤0.01% 1370
2024
Q3
$1.16M Buy
+5,391
New +$1.08M ﹤0.01% 1258
2024
Q2
Sell
-3,247
Closed -$582K 2003
2024
Q1
$582K Sell
3,247
-10,583
-77% -$1.97M ﹤0.01% 1394
2023
Q4
$2.47M Buy
13,830
+10,619
+331% +$1.84M ﹤0.01% 1138
2023
Q3
$568K Sell
3,211
-42,350
-93% -$7.97M ﹤0.01% 1393
2023
Q2
$8.52M Buy
45,561
+7,054
+18% +$1.33M ﹤0.01% 881
2023
Q1
$7.49M Buy
38,507
+34,060
+766% +$6.34M ﹤0.01% 908
2022
Q4
$805K Buy
+4,447
New +$698K ﹤0.01% 1330

Other funds holding MSGS

Amundi's MSGS Position: Q2 2026 in Review

Amundi sold out of Madison Square Garden (MSGS) in Q2 2026, closing a stake of 784 shares — an estimated $252K sold.

Amundi first reported a position in MSGS in Q4 2022 and held it in 12 quarters. The position peaked at $8.52M in Q2 2023. 469 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Amundi reported no remaining Madison Square Garden position as of Q2 2026 after selling out during the quarter.
  • Amundi sold 784 Madison Square Garden shares in Q2 2026, an estimated $252K.
  • Amundi first reported a position in Madison Square Garden in Q4 2022 and held it in 12 quarters.
  • Amundi's Madison Square Garden position peaked at $8.52M in Q2 2023.
  • 469 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.